Reading time: 5 minutes
Maanya Rajasree Katta
Introduction
If you have delayed a colonoscopy, you are not alone. The preparation is lengthy, the cleanse is uncomfortable, and sedation can disrupt an entire day. Yet, colorectal cancer is among the most preventable cancers when detected early through screening. Fortunately, the screening landscape is changing, and two technologies are emerging: capsule endoscopy and robotic-assisted colonoscopy. They aim to make screening more accessible and comfortable, sometimes as simple as swallowing a pill. But before we assume robots will run the show, it is important to understand what these tools are, how they work, and how they might fit into your options.
Why We Need Better Screening Options
Conventional colonoscopy is effective, but that effectiveness means little if you never schedule it. Too many people delay screening until symptoms force the issue, and by then, treatment is harder and outcomes are worse. When colorectal cancer is found early, more than 90% of patients survive at least five years. The challenge is getting people screened in the first place, which is why researchers are developing alternatives patients might actually choose.
Enter the Capsule: Swallowable Camera Technology
An endoscopy is a procedure that allows clinicians to view the inside of the body using a camera. Capsule endoscopy miniaturizes the camera into a swallowable pill that is roughly the size of a large vitamin. The capsule contains cameras and lights that capture thousands of images as it travels through the digestive tract. You swallow it with water, and images are transmitted wirelessly to a recorder worn on a belt. The process is painless, and you can continue your normal activities while it works. The capsule passes naturally and is discarded.
Evidence shows colon capsule endoscopy can detect colorectal cancer and polyps with accuracy comparable to traditional colonoscopy. In the United States, the FDA has cleared PillCam COLON 2 as an adjunctive test for adults after an incomplete colonoscopy with adequate preparation. It is not cleared for primary screening in average-risk patients. In parts of Europe, capsule endoscopy is used for average-risk patients or those unwilling to undergo a conventional colonoscopy.
Artificial intelligence is now assisting capsule workflows, and new systems link telemedicine, cloud infrastructure, and colonoscopy services. AI can, for example, flag suspicious lesions and reduce review time across thousands of images, turning what might be weeks of waiting into days, and making specialist-quality screening possible even in underserved regions.
But capsules have a key limitation: they can find a polyp, but they cannot remove it. That means if something suspicious appears, you will still need a traditional colonoscopy, and some patients end up going through both. Additionally, capsules do not always capture the full colon clearly. While technology continues to improve, complete visualization is not guaranteed.
Robotic-Assisted Colonoscopy: The Next Generation
In a colonoscopy, clinicians use cameras to view the colon. Robotic systems augment conventional colonoscopy by improving control and navigation. Some platforms use automated propulsion to advance more gently, which can reduce discomfort and lower the need for sedation. Clinical comparisons report reductions in patient pain. Other systems add enhanced imaging and AI-assisted polyp detection to help identify lesions that might otherwise be missed. It’s important to keep in mind that these robotic technologies help clinicians, not replace them.
Clinical trials for new robotic platforms are underway and moving toward regulatory review. A potential benefit is access: regions with limited endoscopy services may expand capacity with systems that can help less experienced operators maintain consistent quality.
AI is also being integrated into colonoscopy for real-time polyp detection and quality monitoring. Results vary across studies because training data and methods differ, but the pattern is consistent: AI acts as a second set of eyes while the endoscopist remains in charge.
What Does This Mean for Patients?
Traditional colonoscopy can both diagnose and treat in a single procedure, finding and removing polyps immediately. Capsule systems cannot do this, they can only detect problems, not address them. Robotic platforms improve the experience with gentler navigation and enhanced detection, but they do not replace colonoscopy; they refine it.
These tools expand options. Capsule endoscopy can help when conventional colonoscopy is incomplete, when patients are highly anxious about the procedure, or as a preliminary screen in select scenarios. Robotic systems may improve comfort and detection while preserving the ability to treat polyps during the same visit.
Availability differs by technology. Capsule endoscopy is FDA-cleared and offered at many centers. In the United States, reimbursement is variable and often limited to specific indications, such as incomplete colonoscopy, so patients may face out-of-pocket costs. Robotic systems are in active trials and regulatory processes, and broader availability may follow in the coming years.
The best choice depends on individual factors such as age, family history, prior results, medical conditions, and preferences. These determine the safest and most effective route to complete screening.
Conclusion
The future of colorectal screening is being built around a simple truth: people need options they will actually use. Capsule and robotic technologies are providing those options now, while researchers develop even more sophisticated capabilities. What matters is not which technology wins, but how many lives are saved because screening became something people could say yes to.
Takeaway point: The best screening test is the one that actually gets done. Capsule and robotic-assisted colonoscopy are making that easier, addressing barriers that have kept many people from getting screened. As these technologies continue to develop, they expand options without replacing the need for informed decisions with your clinician.
Header Image Caption and Source: Capsule endoscopy visible in an abdominal X-ray (Hellerhoff, CC BY-SA 4.0 via Wikimedia Commons)
Edited by Mariella Bodemeier Loayza Careaga
References
1. Vuik FER, Nieuwenburg SAV, Moen S, et al. Colon capsule endoscopy in colorectal cancer screening: a systematic review. Endoscopy. 2021;53(8):815-824. doi:10.1055/a-1308-1297
2.Sultan S, Shung DL, Kolb JM, et al. AGA Living Clinical Practice Guideline on Computer-Aided Detection-Assisted Colonoscopy. Gastroenterology. 2025;168(4):691-700. doi:10.1053/j.gastro.2025.01.002
3. Soleymanjahi S, Huebner J, Elmansy L, et al. Artificial Intelligence-Assisted Colonoscopy for Polyp Detection : A Systematic Review and Meta-analysis. Ann Intern Med. 2024;177(12):1652-1663. doi:10.7326/ANNALS-24-00981
4. Spadaccini M, Menini M, Massimi D, et al. AI and Polyp Detection During Colonoscopy. Cancers (Basel). 2025;17(5):797. doi:10.3390/cancers17050797
5. Current state and future development of robotic endoscopy. Dig Endosc. 2024;36(12):1394-1397. doi:10.1111/den.14971
6. ClinicalTrials.gov. (2024, December 27). Visualization of the Colon Through Use of the Magnetic Flexible Endoscope (MFE). Identifier: NCT05833789. Published December 27, 2024. Accessed October 23, 2025. https://clinicaltrials.gov/study/NCT05833789
7. Gibbons E, Kelly OB, Hall B. Advances in colon capsule endoscopy: a review of current applications and challenges. Front Gastroenterol. 2023;2:1316334. https://doi.org/10.3389/fgstr.2023.1316334
OncoBites 
Leave a comment